1. Home
  2. GDTC vs INTG Comparison

GDTC vs INTG Comparison

Compare GDTC & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • INTG
  • Stock Information
  • Founded
  • GDTC 2018
  • INTG 1965
  • Country
  • GDTC Singapore
  • INTG United States
  • Employees
  • GDTC N/A
  • INTG 215
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • INTG Building operators
  • Sector
  • GDTC Health Care
  • INTG Real Estate
  • Exchange
  • GDTC Nasdaq
  • INTG Nasdaq
  • Market Cap
  • GDTC 28.0M
  • INTG 28.9M
  • IPO Year
  • GDTC 2023
  • INTG N/A
  • Fundamental
  • Price
  • GDTC $2.30
  • INTG $12.15
  • Analyst Decision
  • GDTC Buy
  • INTG
  • Analyst Count
  • GDTC 1
  • INTG 0
  • Target Price
  • GDTC $5.00
  • INTG N/A
  • AVG Volume (30 Days)
  • GDTC 29.9K
  • INTG 2.7K
  • Earning Date
  • GDTC 01-01-0001
  • INTG 05-16-2025
  • Dividend Yield
  • GDTC N/A
  • INTG N/A
  • EPS Growth
  • GDTC N/A
  • INTG N/A
  • EPS
  • GDTC N/A
  • INTG N/A
  • Revenue
  • GDTC $368,838.00
  • INTG $59,656,000.00
  • Revenue This Year
  • GDTC N/A
  • INTG N/A
  • Revenue Next Year
  • GDTC N/A
  • INTG N/A
  • P/E Ratio
  • GDTC N/A
  • INTG N/A
  • Revenue Growth
  • GDTC 264.63
  • INTG 4.33
  • 52 Week Low
  • GDTC $1.20
  • INTG $10.70
  • 52 Week High
  • GDTC $4.05
  • INTG $24.67
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 46.24
  • INTG 41.35
  • Support Level
  • GDTC $2.21
  • INTG $12.57
  • Resistance Level
  • GDTC $2.56
  • INTG $13.47
  • Average True Range (ATR)
  • GDTC 0.13
  • INTG 0.64
  • MACD
  • GDTC -0.00
  • INTG -0.08
  • Stochastic Oscillator
  • GDTC 31.58
  • INTG 34.86

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

Share on Social Networks: